Metabolic disorders exacerbate the formation of glial scar after stroke

Julien Clain,David Couret,Matthieu Bringart,Arnaud Lecadieu,Olivier Meilhac,Christian Lefebvre d'Hellencourt,Nicolas Diotel

DOI: https://doi.org/10.1111/ejn.16325

IF: 3.698

2024-04-06

European Journal of Neuroscience

Abstract:A 30‐min MCAO was performed in db/db mice to characterize for the first time the effect of a hyperglycaemic and overweight environment on glial scar formation 3 days after stroke. This metabolic condition increased infarct volume, exacerbated astrogliosis, microgliosis and ECM deposition in the injured hemisphere in the acute phase of stroke. Consequently, hyperglycaemia and overweight aggravate the consequences of stroke by exacerbating and maintaining reactive gliosis after stroke. Metabolic disorders are risk factors for stroke exacerbating subsequent complications. Rapidly after brain injury, a glial scar forms, preventing excessive inflammation and limiting axonal regeneration. Despite the growing interest in wound healing following brain injury, the formation of a glial scar in the context of metabolic disorders is poorly documented. In this study, we used db/db mice to investigate the impact of metabolic perturbations on brain repair mechanisms, with a focus on glial scarring. First, we confirmed the development of obesity, poor glucose regulation, hyperglycaemia and liver steatosis in these mice. Then, we observed that 3 days after a 30‐min middle cerebral artery occlusion (MCAO), db/db mice had larger infarct area compared with their control counterparts. We next investigated reactive gliosis and glial scar formation in db/+ and db/db mice. We demonstrated that astrogliosis and microgliosis were exacerbated 3 days after stroke in db/db mice. Furthermore, we also showed that the synthesis of extracellular matrix (ECM) proteins (i.e., chondroitin sulphate proteoglycan, collagen IV and tenascin C) was increased in db/db mice. Consequently, we demonstrated for the first time that metabolic disorders impair reactive gliosis post‐stroke and increase ECM deposition. Given that the damage size is known to influence glial scar, this study now raises the question of the direct impact of hyperglycaemia/obesity on reactive gliosis and glia scar. It paves the way to promote the development of new therapies targeting glial scar formation to improve functional recovery after stroke in the context of metabolic disorders.

neurosciences